GHRH

Tesamorelin 30mg Vial

Name: Tesamorelin 30mg Vial
Brand: Xenogenix
SKU: xeno-tesamorelin
Price: 1800 ZAR
Availability: InStock

Visceral fat reduction and GH support.

30mg Tesamorelin vial + 2ml bacteriostatic water — clinical-grade GHRH analogue.

R1800

per vial

Ask a specialist

3rd-party verified
Cold-chain shipping
Discreet packaging
99.8% purity

What it is

Tesamorelin is a synthetic growth-hormone-releasing factor (GRF) analogue clinically validated for visceral fat reduction.

Key benefits

Reduces visceral adipose tissue
Supports GH and IGF-1
Improves lipid profiles
Quality of sleep and recovery

How it works

Stimulates the pituitary to release endogenous GH in a physiological pulsatile pattern.

Who it's best for

Visceral fat reduction
Body recomposition
Metabolic recovery

Suggested protocol

Typical research dosing: 1–2mg daily subcutaneous, cycled.

Administration guide

Reconstitute with bacteriostatic water; subcutaneous injection.

Storage instructions

Refrigerate at 2–8 °C after reconstitution. Protect from light.

Frequently asked questions

How quickly will I notice results from Tesamorelin?

Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.

Can I stack this with other Peak Protocol products?

Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.

Is this third-party tested?

Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.

What is the return policy?

Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.

Important disclaimer. All Peak Protocol compounds are intended strictly for laboratory research and educational purposes. They are not approved by the FDA for human consumption, treatment, or therapeutic use. Statements have not been evaluated by the FDA. Consult a qualified medical professional before initiating any protocol.